Archive for month: September, 2022

Cassiopea Partners, jointly with Jefferies, acted as financial advisor to Fine PCB S.p.A. (together with its subsidiaries “Somacis” or the “Group”) and its shareholders, including Green Arrow Private Equity Fund 3 (“Green Arrow”), on the sale to Chequers Capital via Chequers Capital XVII FPCI fund (“Chequers Capital”). Founded in...

Continue reading

Cassiopea Partners acted as financial advisor to Novamont S.p.A. (“Novamont”) in the redefinition of the shareholder agreement between Mater-Bi S.p.A. and Versalis S.p.A. (“Versalis”), which will also imply an increase of Versalis’ stake in Novamont from 25% to 35%. Novamont is an international leading company in the bioplastics sector...

Continue reading